Induction of the Chlamydia muridarum stress/persistence response increases azithromycin treatment failure in a murine model of infection

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 3, 2014, Pages 1782-1784

  Phillips Campbell, R ^a   Kintner, J ^a   Schoborg, R V ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; EXPERIMENTAL INFECTION; LOADING DRUG DOSE; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REPEATED DRUG DOSE; SINGLE DRUG DOSE; STRESS; TREATMENT FAILURE; TREATMENT OUTCOME;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; DRUG RESISTANCE, BACTERIAL; FEMALE; MICE; MICE, INBRED BALB C; STRESS, PHYSIOLOGICAL; TREATMENT FAILURE;

EID: 84896899833     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02097-13     Document Type: Article

References (18)

1. Matsumoto A, Manire GP. 1970. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J. Bacteriol. 101:278-285.
2. Byrne GI, Lehmann LK, Landry GJ. 1986. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 53:347-351. (Pubitemid 16073864)
3. Rank RG, Whittimore J, Bowlin AK, Wyrick PB. 2011. In vivo ultrastructural analysis of the intimate relationship between polymorphonuclear leukocytes and the chlamydial developmental cycle. Infect. Immun. 79:3291-3301. http://dx.doi.org/10.1128/IAI.00200-11.
4. Phillips Campbell R, Kintner J, Whittimore J, Schoborg R. 2012. Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice. Microbes Infect. 14:1177-1185. http://dx.doi.org/10.1016/j.micinf. 2012.07.017.
5. Wyrick PB, Knight ST. 2004. Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. J. Antimicrob. Chemother. 54:79-85. http://dx.doi.org/10.1093/ jac/dkh283. (Pubitemid 39028971)
6. Reveneau N, Crane DD, Fischer E, Caldwell HD. 2005. Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis. Antimicrob. Agents Chemother. 49:1787-1793. http://dx.doi.org/10.1128/AAC.49.5.1787-1793.2005. (Pubitemid 40631590)
7. Kutlin A, Roblin PM, Hammerschlag MR. 1999. In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrob. Agents Chemother. 43:2268-2272. (Pubitemid 29421213)
8. Cotter TW, Miranpuri GS, Ramsey KH, Poulsen CE, Byrne GI. 1997. Reactivation of chlamydial genital tract infection in mice. Infect. Immun. 65:2067-2073. (Pubitemid 27237279)
9. Ramsey KH, Miranpuri GS, Sigar IM, Ouellette S, Byrne GI. 2001. Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect. Immun. 69:5131-5137. http://dx.doi.org/10.1128/IAI.69.8.5131-5137.2001. (Pubitemid 32674500)
10. Workowski KA, Levine W. 2002. Sexually transmitted diseases treatment guidelines-2002. MMWR Morb. Mortal. Wkly. Rep. 51:1-78.
11. Beale AS, Upshon PA. 1994. Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin. Antimicrob. Agents Chemother. 38:1937-1943. http://dx.doi.org/10.1128/AAC.38.9.1937. (Pubitemid 24278782)
12. Pitt RA, Alexander S, Horner PJ, Ison CA. 2013. Presentation of clinically suspected persistent chlamydial infection: a case series. Int. J. STD AIDS 24:469-475. http://dx.doi.org/10.1177/0956462412472815.
13. Horner P. 2006. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. Sex. Transm. Infect. 82:340-343. http://dx.doi.org/10.1136/sti.2005.019158. (Pubitemid 44229455)
14. Wang SA, Papp JR, Stamm WE, Peeling RW, Martin DH, Holmes KK. 2005. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J. Infect. Dis. 191:917-923. http://dx.doi.org/ 10.1086/428290. (Pubitemid 40349807)
15. Seña A, Lensing S, Rompalo A, Taylor S, Martin D, Lopez L, Lee J, Schwebke J. 2012. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with non-gonococcal urethritis: predictors and persistence after therapy. J. Infect. Dis. 206:357-365. http://dx.doi.org/10. 1093/infdis/jis356.
16. Dean D, Suchland RJ, Stamm WE. 2000. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J. Infect. Dis. 182:909-916. http://dx.doi.org/10.1086/315778.
17. Sternak SL, Skerk V. 2010. Determining antimicrobial resistance to Chlamydia trachomatis and applying present findings in daily practice. Med. Glas. (Zenica) 7:26-31. (In Croatian.)
18. Bragina EY, Gomberg MA, Dmitriev GA. 2001. Electron microscopic evidence of persistent chlamydial infection following treatment. J. Eur. Acad. Dermatol. Venereol. 15:405-409. http://dx.doi.org/10.1046/j.1468-3083.2001.00342.x. (Pubitemid 33048754)